Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Stathis
Development of Novel Preclinical Models of Secondary Resistance to the Pi3kδ Inhibitor Idelalisib in Splenic Marginal Zone Lymphoma (Smzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combinatorial Screening of the Pi3k Inhibitor Copanlisib in T Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Integration Between Metabolic Tumour Volume and Metabolic Heterogeneity Predicts Outcome of DLBCL Lymphoma Patients in the Sakk 38/07 Study Cohort
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Mechanisms of Secondary Resistance to Idelalisib in Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Simultaneous Bet/Crebbp/Ep300 Targeting Approach Compared to Single Bet or Crebbp/Ep300 Inhibition in Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Adverse Effect of Steel Particle Contaminants on Fatigue Life of Grease Lubricated Ball Bearings
American Journal of Applied Sciences
Multidisciplinary
